5 alpha reductase inhibitors have shown promise in increasing the detection of prostate cancer in prior ultrasound studies. No studies have been performed looking at the effect of 5 alpha reductase inhibitors on increasing the conspicuity of prostate cancer in MRI. The purpose of this study was to determine if treatment with a 5 alpha reductace inhibitor could increase sensitivity for the detection of prostate cancer in the background setting of benign prostatic hypertrophy.
This abstract and the presentation materials are available to members only; a login is required.